UBS Reiterates Aviva (AIVAF) Buy Recommendation

UBS reiterated a "Buy" recommendation for Aviva (OTCPK:AIVAF) on November 7, 2025, with an average one-year price target of $8.99/share, suggesting a 49.14% upside from its latest closing price of $6.03. Despite a projected 1.36% decrease in annual revenue, institutional sentiment is notably positive, with a 2.31% increase in funds holding positions and a 10.84% rise in total institutional shares owned, alongside a 10.29% increase in average portfolio weight dedicated to the company.

Analysis

UBS reiterated a "Buy" rating for Aviva (AIVAF) on November 7, 2025, with an average one-year price target of $8.99/share. This target implies a significant 49.14% upside from the recent closing price of $6.03, suggesting strong conviction despite a projected 1.36% decrease in annual revenue to 23,931MM. The analyst consensus indicates a potential for substantial capital appreciation, with a non-GAAP EPS forecast at $0.64.

Institutional investor sentiment for Aviva remains robust, with 310 funds reporting positions, an increase of 2.31% over the last quarter. Total institutional shares owned surged by 10.84% to 558,397K shares, while the average portfolio weight dedicated to AIVAF rose by 10.29%. This indicates a growing institutional conviction in the company's prospects.

Several major institutional investors have significantly increased their exposure to Aviva. CAPITAL WORLD GROWTH & INCOME FUND (CWGIX) notably increased its shares by 91.09% and portfolio allocation by 1,224.95%, while EUROPACIFIC GROWTH FUND (AEPGX) increased shares by 31.56% and allocation by 58.69%. Vanguard Total International Stock Index Fund (VGTSX) also raised its allocation by 21.86%, reinforcing the positive institutional trend.

Key Decisions for Investors

• Consider the strong analyst "Buy" rating and the substantial 49.14% implied upside to the average price target of $8.99/share as a potential catalyst for capital appreciation.
• Evaluate the positive institutional flow, evidenced by a 10.84% increase in shares owned and a 10.29% rise in average portfolio weight, as a potential indicator of sustained demand and confidence.
• Monitor future revenue trends closely, given the projected 1.36% decrease, to assess if the positive sentiment is primarily valuation-driven or if fundamental growth concerns could emerge.